Cloning Matters.

Sir Ian Wilmut

Cloning is an advance technological invention for producing a genetic twin of a living thing, an organism that starts life with the same genes as of its parents. In 1997, researchers at Scotland’s institute, led by embryologist Ian Wilmut successfully cloned a lamb—named Dolly—from the cell of adult "ewe" and this was of its first kind in the world. Sir Ian Wilmut is an English embryologist born on 7^th July 1944 in Hampton Lucy, Warwickshire, England is best known for cloning. He has been awarded with some prestigious awards of OBE, FRS, FMedsci, 1997 Time man of the year runner up.

The ethics of cloning is an extremely controversial issue. The term is generally used to refer to artificial human cloning; human clones in the form of identical twins are commonplace with there cloning occurrence during the natural process of reproduction. There are two commonly discussed types of human cloning : “ Therapeutic Cloning and reproductive Cloning “. Therapeutic  cloning involves cloning cells from an adult for use in medicine and is an active area of research. Reproductive Cloning would involve making cloned humans. A third type of cloning is called “ Replacement Cloning “ is a theoretical possibility, and would be a combination of therapeutic and reproductive cloning. Every such inventions has some merits and demerits. Human cloning could be misused to destroy the existing humanity and civilization. We have seen the proliferation of weapons of mass destruction and the spectrum of germs and chemical warfare. Scientist, Philosophers, Thinkers, Philanthropists from all over the world spoke out against human cloning, prompted by fears that the world has taken a step further towards nightmare of humans replicated in the laboratory. The human cloning can tear the society into pieces, it can endanger the very existence of human being in this world. Advocates of human therapeutic cloning believe that the practice could provide genetically identical cells for regenerative medicine, tissues and organs would neither trigger an immune response nor require the use of Immunosuppressive drugs. Both the basic research and therapeutic development for serious disease such as cancer, heart disease and diabetes, as well as improvements in burn treatment and reconstructive and cosmetic surgery, are areas that might benefit from such new technology.